Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions.
Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy.
Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics though rare cell analysis.
Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy.
Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics though rare cell analysis.
Location: United States, Washington, Seattle
Employees: 51-200
Total raised: $96.05M
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| - | HealthQues... | healthques... |
| - | F-Prime Ca... | fprimecapi... |
| - | Telegraph ... | thpartners... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 27.06.2024 | - | $20M | - |
| 10.09.2021 | - | $24.05M | - |
| 26.12.2019 | - | $22M | - |
| 29.08.2017 | - | $30M | - |
Mentions in press and media 19
| Date | Title | Description |
| 01.07.2024 | RareCyte: $20 Million Raised To Expand Orion Spatial Biology Platform | RareCyte, a life sciences company offering advanced Precision Biology platforms, including instruments, reagents, software, and services, announced the completion of $20 million in funding from new and existing investors. New investor Fores... |
| 27.06.2024 | RareCyte Secures $20M Financing | RareCyte, a Seattle, WA-based Life Sciences company providing precision biology platforms including instruments, reagents, software, and services, raised $20M in funding. The round was led by Forest Road, Arboretum Ventures and F-Prime Capi... |
| 18.01.2024 | SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio | - |
| 14.09.2021 | RareCyte Secures $24M Financing | RareCyte, Inc., a Seattle, WA-based Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, raised $24M in financing. Arboretum Ventures led the financing joined by other new investors ... |
| 10.09.2021 | RareCyte, Inc. announced that it has received $24.046147 million in funding from Arboretum Ventures LLC, F Prime, Inc., Agilent Technologies, Inc., HealthQuest Capital, 5AM Venture Management, LLC | On September 10, 2021, RareCyte, Inc. closed the transaction. The company has received $46,147 in its second and final tranche closing. The company raised a total of $24,046,147 in the transaction from 27 investors. |
| 10.09.2021 | Seattle startup RareCyte raises $24M to advance new high-speed cell imaging platform | Different immune cells imaged on a section of tonsil by the RareCyte Orion platform. Distinct cell types are in green, red and white, cell nuclei are in blue. (RareCyte Image) Seattle-based startup RareCyte announced $24 million in new fund... |
| 09.09.2021 | RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels | |
| 09.09.2021 | RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels | SEATTLE, Sept. 9, 2021 /PRNewswire/ -- RareCyte, Inc. ("RareCyte" or "the Company") a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the com... |
| 26.12.2019 | RareCyte Closes $22 Million In Funding | RareCyte, a rare cell analysis company, announced it has raised $22 million in funding led by HealthQuest Capital RareCyte — a rare cell analysis company — announced it has raised $22 million from new and existing investors. This round of f... |
| 23.12.2019 | RareCyte Raises $22M Financing Round | RareCyte, Inc., a Seattle, WA-based life sciences company, completed a $22M financing round. The round was led by HealthQuest Capital, with participation from 5AM Ventures and company founder, Ron Seubert. In conjunction with the funding, D... |
Show more